PTPA and neoplasm: Protein phosphatase 2A(PP2A) is recognised as a regulator of the tumour microenvironment (173), which can inhibit mTORC1-induced LAT1 and glycolysis, and there is a negative crosstalk between PP2A and mTORC1 (174).